Annual D&A:
$2.60M+$1.08M(+70.87%)Summary
- As of today, ARQT annual D&A is $2.60 million, with the most recent change of +$1.08 million (+70.87%) on December 31, 2024.
- During the last 3 years, ARQT annual D&A has risen by +$2.15 million (+472.47%).
- ARQT annual D&A is now at all-time high.
Performance
ARQT Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$562.00K+$152.00K(+37.07%)Summary
- As of today, ARQT quarterly D&A is $562.00 thousand, with the most recent change of +$152.00 thousand (+37.07%) on September 30, 2025.
- Over the past year, ARQT quarterly D&A has dropped by -$870.00 thousand (-60.75%).
- ARQT quarterly D&A is now -82.06% below its all-time high of $3.13 million, reached on March 31, 2025.
Performance
ARQT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$4.56M-$870.00K(-16.02%)Summary
- As of today, ARQT TTM D&A is $4.56 million, with the most recent change of -$870.00 thousand (-16.02%) on September 30, 2025.
- Over the past year, ARQT TTM D&A has increased by +$1.68 million (+58.07%).
- ARQT TTM D&A is now -16.02% below its all-time high of $5.43 million, reached on June 30, 2025.
Performance
ARQT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ARQT Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +70.9% | -60.8% | +58.1% |
| 3Y3 Years | +472.5% | +55.7% | +340.8% |
| 5Y5 Years | +3722.1% | +236.5% | +1207.2% |
ARQT Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +472.5% | -82.1% | +165.1% | -16.0% | +340.8% |
| 5Y | 5-Year | at high | +3722.1% | -82.1% | +238.6% | -16.0% | +1207.2% |
| All-Time | All-Time | at high | >+9999.0% | -82.1% | +2241.7% | -16.0% | >+9999.0% |
ARQT Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $562.00K(+37.1%) | $4.56M(-16.0%) |
| Jun 2025 | - | $410.00K(-86.9%) | $5.43M(+1.1%) |
| Mar 2025 | - | $3.13M(+583.8%) | $5.37M(+106.7%) |
| Dec 2024 | $2.60M(+70.9%) | $458.00K(-68.0%) | $2.60M(-9.9%) |
| Sep 2024 | - | $1.43M(+308.0%) | $2.89M(+73.2%) |
| Jun 2024 | - | $351.00K(-2.0%) | $1.67M(-11.2%) |
| Mar 2024 | - | $358.00K(-51.9%) | $1.88M(-0.3%) |
| Dec 2023 | $1.52M(+62.8%) | $745.00K(+251.4%) | $1.88M(+20.2%) |
| Sep 2023 | - | $212.00K(-62.2%) | $1.56M(-8.7%) |
| Jun 2023 | - | $561.00K(+54.5%) | $1.71M(+23.6%) |
| Mar 2023 | - | $363.00K(-15.4%) | $1.39M(+10.7%) |
| Dec 2022 | $934.00K | $429.00K(+18.8%) | $1.25M(+21.1%) |
| Sep 2022 | - | $361.00K(+54.3%) | $1.03M(+19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $234.00K(+2.2%) | $866.00K(+6.4%) |
| Mar 2022 | - | $229.00K(+8.5%) | $814.00K(+6.7%) |
| Dec 2021 | $454.00K(+272.1%) | $211.00K(+9.9%) | $763.00K(+6.3%) |
| Sep 2021 | - | $192.00K(+5.5%) | $718.00K(+3.6%) |
| Jun 2021 | - | $182.00K(+2.2%) | $693.00K(+22.0%) |
| Mar 2021 | - | $178.00K(+7.2%) | $568.00K(+24.8%) |
| Dec 2020 | $122.00K(+79.4%) | $166.00K(-0.6%) | $455.00K(+30.4%) |
| Sep 2020 | - | $167.00K(+193.0%) | $349.00K(+91.8%) |
| Jun 2020 | - | $57.00K(-12.3%) | $182.00K(+45.6%) |
| Mar 2020 | - | $65.00K(+8.3%) | $125.00K(+48.8%) |
| Dec 2019 | $68.00K(>+9900.0%) | $60.00K(+150.0%) | $84.00K(+250.0%) |
| Mar 2019 | - | $24.00K | $24.00K |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual D&A year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly D&A year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM D&A year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual D&A?
The current annual D&A of ARQT is $2.60M
What is the all-time high annual D&A for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual D&A is $2.60M
What is Arcutis Biotherapeutics, Inc. annual D&A year-on-year change?
Over the past year, ARQT annual D&A has changed by +$1.08M (+70.87%)
What is Arcutis Biotherapeutics, Inc. quarterly D&A?
The current quarterly D&A of ARQT is $562.00K
What is the all-time high quarterly D&A for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly D&A is $3.13M
What is Arcutis Biotherapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, ARQT quarterly D&A has changed by -$870.00K (-60.75%)
What is Arcutis Biotherapeutics, Inc. TTM D&A?
The current TTM D&A of ARQT is $4.56M
What is the all-time high TTM D&A for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM D&A is $5.43M
What is Arcutis Biotherapeutics, Inc. TTM D&A year-on-year change?
Over the past year, ARQT TTM D&A has changed by +$1.68M (+58.07%)